Masimo (NASDAQ:MASI) Stock Rating Lowered by Raymond James Financial

Masimo (NASDAQ:MASI) was downgraded by investment analysts at Raymond James Financial from an “outperform” rating to a “market perform” rating in a report released on Friday, MarketBeat reports.

Other research analysts also recently issued research reports about the stock. Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research note on Wednesday, March 18th. Weiss Ratings reissued a “sell (d)” rating on shares of Masimo in a research note on Thursday, January 22nd. BTIG Research cut shares of Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Stifel Nicolaus set a $180.00 target price on Masimo in a research note on Tuesday, February 17th. Finally, Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 target price on the stock. in a report on Tuesday, February 17th. Eight equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and an average price target of $181.17.

Masimo Stock Up 0.1%

Masimo stock opened at $177.11 on Friday. Masimo has a 1-year low of $125.94 and a 1-year high of $179.00. The company has a market cap of $9.51 billion, a PE ratio of -16.80, a price-to-earnings-growth ratio of 1.79 and a beta of 1.21. The stock’s 50 day moving average price is $159.93 and its 200 day moving average price is $148.32. The company has a debt-to-equity ratio of 0.72, a current ratio of 2.49 and a quick ratio of 1.47.

Hedge Funds Weigh In On Masimo

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Jupiter Asset Management Ltd. bought a new stake in shares of Masimo during the 3rd quarter worth $12,491,000. American Century Companies Inc. grew its position in Masimo by 10.6% during the 3rd quarter. American Century Companies Inc. now owns 168,341 shares of the medical equipment provider’s stock worth $24,839,000 after purchasing an additional 16,113 shares in the last quarter. ING Groep NV acquired a new stake in Masimo during the 3rd quarter valued at $3,069,000. Citigroup Inc. raised its position in Masimo by 133.5% during the third quarter. Citigroup Inc. now owns 116,672 shares of the medical equipment provider’s stock valued at $17,215,000 after buying an additional 66,710 shares during the period. Finally, 4D Advisors LLC lifted its position in Masimo by 50.0% in the 2nd quarter. 4D Advisors LLC now owns 45,000 shares of the medical equipment provider’s stock worth $7,570,000 after buying an additional 15,000 shares in the last quarter. 85.96% of the stock is owned by institutional investors.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.